Tag: Gilead Sciences Inc

Novartis CEO Warns of US Drug Pricing Policy Challenges Under Trump

April 28, 2026

Novartis CEO Warns of US Drug Pricing Policy Challenges Under Trump

Europe’s Fragmented Markets: Capital, Pricing, and Reimbursement Challenges

April 11, 2026

Europe’s Fragmented Markets: Capital, Pricing, and Reimbursement Challenges

FDA’s Vaccine Chief to Exit Amid Drug Approval Concerns & Industry Criticism

March 7, 2026

FDA’s Vaccine Chief to Exit Amid Drug Approval Concerns & Industry Criticism

Web Analytics Made Easy - Statcounter